[
    [
        {
            "time": "2021-06-23",
            "original_text": "纳微科技上市首日涨12倍，中一签能赚超5万。",
            "features": {
                "keywords": [
                    "纳微科技",
                    "上市首日",
                    "暴涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "纳微科技上市首日涨12倍，中一签能赚超5万。",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 10,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "基因细胞治疗CDMO：新兴赛道蓬勃发展。",
            "features": {
                "keywords": [
                    "基因细胞治疗",
                    "CDMO",
                    "新兴赛道"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "基因细胞治疗CDMO：新兴赛道蓬勃发展。",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "北向资金合计净流入81.99亿元，药明康德、美的集团、韦尔股份净买入居前。",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流入",
                    "药明康德"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "家电",
                    "半导体"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金合计净流入81.99亿元，药明康德、美的集团、韦尔股份净买入居前。",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "数据复盘｜电子、汽车等7个行业获主力资金青睐，北向资金抢筹药明康德等股。",
            "features": {
                "keywords": [
                    "数据复盘",
                    "主力资金",
                    "北向资金",
                    "药明康德"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电子",
                    "汽车",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "数据复盘｜电子、汽车等7个行业获主力资金青睐，北向资金抢筹药明康德等股。",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "科创板最牛新股诞生，纳微科技上市首日暴涨1274%，机构纷纷看好。",
            "features": {
                "keywords": [
                    "科创板",
                    "纳微科技",
                    "暴涨",
                    "机构看好"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "科创板最牛新股诞生，纳微科技上市首日暴涨1274%，机构纷纷看好。",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "药明康德参股公司纳微科技在科创板挂牌上市。",
            "features": {
                "keywords": [
                    "药明康德",
                    "参股公司",
                    "纳微科技",
                    "科创板"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明康德参股公司纳微科技在科创板挂牌上市。",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "医药股在香港集体爆发，行业多重利好催化审评审批效率提速。",
            "features": {
                "keywords": [
                    "医药股",
                    "香港",
                    "审评审批",
                    "效率提速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药股在香港集体爆发，行业多重利好催化审评审批效率提速。",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "药品审评审批“速”“质”提升，全面利好医药行业发展。",
            "features": {
                "keywords": [
                    "药品审评审批",
                    "速度",
                    "质量",
                    "医药行业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药品审评审批“速”“质”提升，全面利好医药行业发展。",
                "Correlation": 5,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 6,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "上海瀛翊违规减持药明康德，三大谜团待解及其他违规处罚。",
            "features": {
                "keywords": [
                    "上海瀛翊",
                    "违规减持",
                    "药明康德",
                    "处罚"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海瀛翊违规减持药明康德，三大谜团待解及其他违规处罚。",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]